This prospective study was designed according to the Helsinki Declaration and good clinical study guidelines. The individuals were examined with a 1.5 T magnetic resonance scanner (Siemens MAGNETOM Aera) in the department of radiology of a university hospital with routine clinical indications.
A radiologist with more than 15 years of experience in neuroradiology performed all investigations. The radiologist was blinded to the clinical inspection findings, laboratory results, early clinically suspected differential diagnoses, and final diagnoses of the patients.
A total of 350 subjects were evaluated in our MRI department from January 2016 to July 2016. Images from 17 patients were not obtained in sufficient quality because of patient movement. These 17 patients and 48 patients who did not want to participate in the study were excluded. Finally, 285 cases were included and 58 of these were evaluated as ELC-positive.
A survey questionnaire was filled out by all participants after approval of the information form. First questions were asked about age, sex, hypertension, diabetes mellitus, and smoking; then the presence of neurological complaints, such as headache, dizziness, walking imbalance, sudden neurological complaints, and double vision, was addressed; and finally the presence of the ELC was evaluated by inspection.
Magnetic resonance imaging analysis
The standard MRI protocol for neuroimaging was as follows: T2-weighted axial plane, voxel size (VS) 0.9 mm × 1.12 mm, slice thickness (ST) 3 mm, interslice distance (ISD) 0.3 mm, TE 110 ms, TR 4250 ms, flip angle 90°, fluid attenuated inversion recovery (FLAIR); axial plane, sagittal plane, VS 0.9 mm × 1.12 mm, ST 4 mm, ISD 0.4 mm, TE 100 ms, TR 4000 ms, T1-weighted VS 0.94 mm × 1.13 mm × 2 mm, TE 4.6 ms, TR 9.1 ms, axial plane, VS 2.05 mm × 2.56 mm, ST 5 mm, ISD 1 mm, TE 25 ms, TR 700 ms, flip angle 90°. All images were stored in our hospital's PACS DATA system.
The MRI studies were evaluated by a radiologist with more than 15 years of neuroradiology experience. The Fazekas scale (10) was used to evaluate WMIs, especially on T2W FLAIR sequences, as an indicator of ischemic small vessel disease and brain aging.
The T1WI and T2WI sequences were evaluated. T1WI is commonly used to evaluate anatomy and T2WI is used for additional pathological findings.
Cerebral hyperintensity classification system of Fazekas
The level of WMI was scored on the special cerebral hyperintensity classification system of Fazekas with fourpoint scale. The classification was evaluated on MRI images with the T1W, T2W, and FLAIR sequences. Images from Fazekas 0-3 scale examples are demonstrated in Figure 2 .
WMIs on MRI were described as indistinct hyperintense foci of 5 mm on both transverse T2 and FLAIR images. Ischemic lacunae were well-defined regions of hyperintense focuses of 2 mm on T2 as well as similar intensity of cerebrospinal fluid. Foci with similar size and appearance were considered as perivascular spaces. Nevertheless, perivascular spaces neighboring the anterior commissure may be larger. Basal ganglia lesions were evaluated similarly to white matter lesions, even those located in the gray matter.
WMIs and lacuna observed on MRI in the elderly population are often regarded as a sign of ischemic small vessel disease. The overall degree of WMI in the brain can be assessed with the Fazekas scale. We used a four-point Fazekas scale scoring system to classify the WMIs. Fazekas score of 0 indicated normal white matter intensity without F1 is accepted as normal in older adults. F2 and F3 are considered pathological, but may be seen in cases with normal intellect and function. On the other hand, this was a high-risk population for intellectual and functional loss, as subjects in the Fazekas 3 group have a 25% loss of function within 1 year (11) . Three-year follow-up showed rapid functional loss in these patients with severe white matter lesions (12).
Statistical analysis
Continuous variables are presented as mean ± standard deviation, and categorical variables are presented as percentages.
The differences between the categorical variables between the groups were evaluated by chi-square test. P < 0.05 was considered significant. Sensitivity and specificity values were calculated when a significant threshold was found. Statistical analysis was performed with SPSS 22.0 (13).
Results
Analysis of the study population is presented in Table 1 . Mean age was 58 ± 16 years. The ELC was found in 58 (20%) patients. A total of 233 (81%) patients had normal WMI compared to 52 (19%) patients who had abnormal WMI. Two groups were created from among the patients: group A had normal WMIs (Fazekas 0), and group B had abnormal WMIs (Fazekas score of ≥1). Age, presence of the ELC, and hypertension differed significantly between the two groups ( Table 2 ). The frequency of WMI according to the incidence of the ELC is demonstrated in Figure 3 .
Binary logistic regression analysis was performed to identify the independent determinants of abnormal WMI (Table 3) . It demonstrated that age (95% confidence interval [CI]: 1.105-1.213, P < 0.001) and the ELC (95% CI: 0.098-0.783, P = 0.015) were independent determinants of the existence of abnormal WMI.
We also calculated the specificity and sensitivity of the ELC in terms of diagnosing abnormal WMI. The ELC predicted abnormal WMI with 89% specificity and 62% sensitivity.
Discussion
In the present study, we have found a significant relationship between ELC and asymptomatic WMI. The ELC may be useful to predict WMI abnormalities with high sensitivity and specificity in an apparently healthy population.
The incidence of cognitive impairment is increasing with aging, and its social, economic, and emotional burden is immense (14) . Understanding the etiopathogenesis of impaired consciousness associated with aging can prevent this condition and protect cognitive abilities. Brain lesions due to ischemic small vessel disease and especially WMI have independently been related with cognitive impairment. Evidence suggests that white matter changes have a significant impact on daily activities, including gait and executive functioning. Silent brain infarction, i.e. WMI and lacunae viewed as cerebral small vessel disease, is being reported more frequently in older people with the development of medical technology (15) . The Rotterdam MRI Scan Study showed that newly developed silent brain infarcts are associated with the presence of cardiovascular risk factors, such as hypertension, dyslipidemia, diabetes, carotid plaques, smoking, and age (15) . Several reports revealed that the increasing severity of WMI and lacunae is related to a decline in cognitive function scores in these patients (15) . Risks for cardiovascular disease and the development of cognitive impairment are the same. Cerebrovascular disease is considered an important contributing factor to vascular cognitive impairment. Furthermore, silent brain infarction provoked by small vessel disease, rather than large cortical cerebral infarction, is more considerable in the occurrence of vascular cognitive decline, although various cardiovascular risk factors are related with the development of both types of cerebral infarction.
The relationship between cerebrovascular events and CAD suggests that brain and cardiovascular diseases may have similar etiopathogenesis, although both are strongly associated with advanced age.
There is little known in terms of the possible etiopathogenesis producing ischemic small vascular disease in the brain and injury of CAD. However, the etiopathogenesis of both disease groups is closely related to atherosclerosis due to hypertension, endothelial damage, and local inflammatory events.
The possible relationship between the ELC and CAD was first reported by Frank in 1973 (16) . A recent review of the skin manifestations of atherosclerosis suggests that ELC may be an early marker of atherosclerosis (17) . A metaanalysis suggested that ELC may be an early sign of CAD with 67% specificity and 62% sensitivity (18) . In spite of these results, no certain statement of etiopathogenesis was determined between ELC and CAD.
The myocardium and ELC have a common genetic microvascular origin (19) and therefore the ELC and CAD are thought to be formed by a common pathophysiological process due to atherosclerosis.
In addition, the ELC is significantly associated with increased arterial stiffness and carotid intima media thickness, which are considered surrogate markers of atherosclerosis.
Several limitations to our study should be mentioned. The size of the study was relatively small and it may not reflect the general population, as we did not include patients with overt cerebrovascular disease. The clinical significance of the WMIs found in our study was not established because of the absence of long-term followup. We also did not grade WMI abnormalities because only a few patients had a Fazekas score of ≥3. We attribute this to the study protocol, whereby we included only asymptomatic patients. Finally, our study design was crosssectional; therefore, it did not provide any details related to the causative mechanisms of the association between the ELC and WMI.
In conclusion, although the etiopathogenesis of the relation between the ELC and WMI remains to be clarified, this is the first study to report a highly positive association between the ELC and WMI in a large group of participants. Physicians could obtain valuable information related to the white matter of the brain by observing the ELC during clinical examinations. (Fazekas 1, 2, and 3) . WMI: White matter intensity, ELC: earlobe crease. 
